ELLA-MARIE RAKOWSKI: Open Payments
NPI 1134761984 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,263 in 125 payments from 14 companies in 2025. Trend: 2023 $1,820 · 2024 $1,496 · 2025 $2,263
Food & beverage: $2,163Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $479 |
| GENZYME CORPORATION | 11 | $315 |
| Novartis Pharmaceuticals Corporation | 21 | $289 |
| Regeneron Healthcare Solutions, Inc. | 9 | $267 |
| ABBVIE INC. | 14 | $220 |
| PFIZER INC. | 17 | $216 |
| Galderma Laboratories, L.P. | 16 | $180 |
| UCB, Inc. | 3 | $88 |
| Organon LLC | 7 | $64 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
Products named: DUPIXENT, TREMFYA, CIBINQO, COSENTYX, NEMLUVIO, RINVOQ, SKYRIZI, Bimzelx.
Industry payments across CO — which companies pay providers there.
